L. Michaud

发表

The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer.

L. Michaud, 2009 .

Complete Estrogen Blockade for the Treatment of Metastatic and Early Stage Breast Cancer

A. Buzdar, L. Michaud, 2000, Drugs & aging.

Complementary/alternative therapies. Potential safety issues in cancer care.

L. Michaud, 2000, Cancer practice.

Risks and Benefits of Taxanes in Breast and Ovarian Cancer

G. Hortobagyi, V. Valero, L. Michaud, 2000, Drug safety.

Effect of CYP2D6 polymorphisms on breast cancer recurrence

G. Hortobagyi, L. Pusztai, A. González-Angulo, 2012, Cancer.

Combination endocrine therapy in the management of breast cancer.

A. Buzdar, L. Michaud, K. Jones, 2001, The oncologist.

Usage of erythropoiesis‐stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia

Maria A. Rodriguez, A. Buzdar, A. Ferrajoli, 2011, Cancer.

Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients

K. Jones, L. Michaud, Bonnie L Boster, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dietary supplements in patients with cancer: risks and key concepts, part 1.

K. Jones, L. Michaud, J. Espirito, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.

L. Michaud, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Current Controversies in Bone Health and Osteoporosis Prevention and Treatment: The Experts Answer Questions from Health-System Pharmacists

E. MacLaughlin, L. Michaud, S. Vondracek, 2010 .

Cancer-treatment-induced bone loss, part 2.

S. Goodin, L. Michaud, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.

G. Hortobagyi, V. Valero, B. Hennessy, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

A. Buzdar, L. Michaud, 1999, Drug safety.

Myeloid growth factors clinical practice guidelines in oncology.

J. Armitage, G. Demetri, G. Lyman, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Treatment-experienced breast cancer.

L. Michaud, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Recent Advances in the Systemic Management of Metastatic Breast Cancer

K. Jones, L. Michaud, 2002 .

Efficacy of Anastrozole in a Consecutive Series of Advanced Breast Cancer Patients Treated with Multiple Prior Chemotherapies and Endocrine Agents: M. D. Anderson Cancer Center Experience

A. Buzdar, L. Michaud, A. Jolynn Knoche, 1999, The breast journal.

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

G. Hortobagyi, V. Valero, D. Booser, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The Epothilones: How Pharmacology Relates to Clinical Utility

L. Michaud, 2009, The Annals of pharmacotherapy.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Antiemesis Panel Members

D. Ettinger, M. Kris, H. Rugo, 2010 .

AntiemesisPractice Guidelines in Oncology TM

P. Bierman, D. Ettinger, M. Kris, 2009 .

Myeloid growth factors. Clinical practice guidelines in oncology.

J. Armitage, G. Demetri, G. Lyman, 2007, The Journal of the National Comprehensive Cancer Network.

Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Orthopedic nursing.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.

D. Kiel, C. Cooper, M. Hochberg, 2020, Journal of orthopaedic trauma.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition

D. Kiel, C. Cooper, M. Hochberg, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.

G. Hortobagyi, D. Bodurka, K. Basen-Engquist, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel‐Associated Epiphora

P. Kintzel, L. Michaud, M. K. Lange, 2006, Pharmacotherapy.

Incidence, risk factors, and management of infusion-related reactions in breast cancer patients receiving trastuzumab.

Kenneth R Hess, K. Hess, G. Hortobagyi, 2014, The oncologist.

Myeloid growth factors.

J. Armitage, G. Demetri, G. Lyman, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting.

L. Michaud, C. Barnett, A. Landgraf, 2012, Journal of the American Pharmacists Association : JAPhA.

Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

K. Hess, G. Hortobagyi, V. Valero, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dietary supplements in patients with cancer: risks and key concepts, part 2.

K. Jones, L. Michaud, J. Espirito, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Methods for Preventing Reactions Secondary to Cremophor El

L. Michaud, 1997, The Annals of pharmacotherapy.

Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.

L. Michaud, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Trastuzumab treatment and the risk of central nervous system (CNS) metastases

G. Hortobagyi, R. Theriault, F. Esteva, 2007 .

Cancer-treatment-induced bone loss, part 1.

S. Goodin, L. Michaud, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Women in oncology pharmacy leadership: A white paper

D. W. Henry, R. Schwartz, L. Michaud, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Off-label drug use in women with breast cancer.

S. Fang, S. Giordano, W. Dean-Colomb, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.